September 27, 2022 September 27, 2022Categories Press ReleasesMedia Advisory: Journal of Clinical Oncology publishes outcomes from the practice-changing DREAMseq trial in patients with advanced melanoma
September 8, 2022 September 8, 2022Categories Press ReleasesPress Release: ECOG-ACRIN completes the first randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer
July 14, 2022 July 14, 2022Categories Press ReleasesMedia Advisory: Blood publishes long-term outcomes of patients with CLL in the practice-changing E1912 trial
May 27, 2022 May 27, 2022Categories Press ReleasesPress Release: ECOG-ACRIN research highlights at ASCO 2022
May 17, 2022 May 17, 2022Categories Press ReleasesMedia Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio
March 25, 2022 March 25, 2022Categories Press ReleasesPress Release: Enrollment in TMIST breast cancer screening trial surpasses halfway mark; recruitment of women from diverse backgrounds is key to success
March 16, 2022 March 16, 2022Categories Press ReleasesPress Release: ECOG-ACRIN opens a new NCI-MATCH treatment arm for dMMR and LAG-3-positive cancers as it continues to locate patients with BRAF mutations
December 21, 2021 December 21, 2021Categories Press ReleasesPress Release: A new post-surgery approach for treating HPV-related throat cancer uses less radiation safely and spares the majority of patients from chemotherapy
November 16, 2021 November 16, 2021Categories Press ReleasesPress Release: Practice-changing trial results for advanced skin cancer
